SCHEMBL9048383

SCHEMBL9048383

N#C[C@@H]1CSCN1C(=O)[C@H]1CCCN1C(=O)CCc1cc2ccccc2o1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PREP P48147 7/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9048372 1.00 PREP (0.57) PREP
SCHEMBL9049043 0.91 PREP (0.67) PREP
SCHEMBL9049047 0.91 PREP (0.67) PREP
SCHEMBL9047456 0.89 PREP (0.63) PREP
SCHEMBL9046539 0.84 PREP (0.55) PREP
SCHEMBL9046528 0.84 PREP (0.55) PREP
SCHEMBL9047132 0.83 PREP (0.57) PREP
SCHEMBL9046433 0.83 PREP (0.46) PREP
SCHEMBL9046426 0.83 PREP (0.46) PREP
SCHEMBL9049839 0.82 PREP (0.52) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed